Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study.
J Indian Med Assoc
;
2003 Feb; 101(2): 113-4, 123
Article
in English
| IMSEAR
| ID: sea-105706
ABSTRACT
The efficacy and safety of combined metformin and rosiglitazone therapy in type 2 diabetes has been evaluated in an open-label, phase IV, prospective, multicentre study conducted in India over a period of 3 months in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki. The superiority of the combination therapy in its effects on glycaemic parameters and lipid profile has been observed. A discussion of the same with brief review of literature has been presented here.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Product Surveillance, Postmarketing
/
Thiazoles
/
Aged
/
Female
/
Humans
/
Male
/
Prospective Studies
/
Analysis of Variance
/
Treatment Outcome
/
Adult
Type of study:
Controlled clinical trial
/
Observational study
Language:
English
Journal:
J Indian Med Assoc
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS